Rutgers: Novel Antibiotic Succeeds in Trial Against Hospital-Acquired Pneumonia
May 17, 2023
May 17, 2023
NEW BRUNSWICK, New Jersey, May 17 (TNSjou) -- Rutgers University issued the following news:
A Rutgers researcher leading a trial found that the novel combination antibiotic sulbactam-durlobactam combats dangerous pneumonia at least as well as the best currently approved treatment.
The findings have led a unanimous expert committee to recommend that the Food and Drug Administration (FDA) approve the new drug, which could be available this summer to combat the often-fatal . . .
A Rutgers researcher leading a trial found that the novel combination antibiotic sulbactam-durlobactam combats dangerous pneumonia at least as well as the best currently approved treatment.
The findings have led a unanimous expert committee to recommend that the Food and Drug Administration (FDA) approve the new drug, which could be available this summer to combat the often-fatal . . .